BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2003
View Archived Issues
Novel protein kinase inhibitors in early development at Aventis
Read More
Pfizer claims new GlyT-1 inhibitors for psychosis and other disorders
Read More
New antiprotozoal protein kinase inhibitors identified by Merck researchers
Read More
Increased survival associated with antitumor T-cell response in ovarian cancer
Read More
Effective dose of darbepoetin alfa for increasing preoperative hemoglobin levels
Read More
No significant effects reported for celecoxib on fracture healing in rats
Read More
Atazanavir reported safe and effective in reducing HIV infection
Read More
Takeda designs new antidiabetic agents
Read More
Recent patent reports novel PDE4 inhibitors with utility in asthma and other disorders
Read More
Kissei scientists design new series of SGLT-2 inhibitors
Read More
Bayer patent covers thiazole-based agents for HSV
Read More
Antiparkinsonian agents with novel mechanism of action
Read More
Novel PLA2 inhibitors discovered by Nippon Soda scientists
Read More
ATL-1102 cleared to enter clinical trials
Read More
Preoperative epoetin alfa reduces blood transfusion requirement in knee or hip arthroplasty
Read More
AstraZeneca files European MAA for Faslodex in advanced breast cancer
Read More
Vical to develop DNA vaccine against CMV
Read More
Serono's Raptiva marketing rights extended to Asia
Read More
Boehringer Ingelheim initiates phase III RESIST program for tipranavir
Read More
Medtronic to exclusively market rhBMP-2 in Europe
Read More
Cerus begins phase I trial of EBV vaccine
Read More
Access program launched for cetuximab
Read More
Preclinical anti-HIV development candidate presented at medicinal chemistry conference
Read More
Design and synthesis of potent and selective direct thrombin inhibitors
Read More
LY-355703 associated with peripheral neuropathy and myalgia in early clinical studies
Read More
New inhibitors of iNOS with oral antiinflammatory activity identified at AstraZeneca
Read More